Request:  A global pharmaceutical sponsor conducting a Phase III clinical trial required Semaglutide, a GLP-1 receptor agonist, as a...

We are excited to announce that CSI will be attending the Global Clinical Supplies Group (GCSG) US Conference in San Antonio, Texas,...

Exciting news! CSI will be exhibiting at GCSG Asia Pacific 2024 this week, on March 12-13 in Seoul! Visit us at Table 7 to learn how our...

A Leading Biotech Client's Challenge A leading biotech client approached CSI to assist in sourcing the comparator drug Lucentis for a...

Which Trends Will Shape Clinical Trial Supplies in 2025? The clinical trial supply industry is rapidly evolving. This change is driven by...

At Clinical Services International (CSI), we continually strive to exceed the expectations of our pharmaceutical and biotech partners by...

Request:  CSI was tasked with sourcing a vast quantity of Venetoclax and Azacitidine for a large pharmaceutical company's global study on...

CSI is excited to have our Managing Director Vanessa Dekou featured on the front cover of Life Sciences Magazine!  This recognition is...

Ensuring Efficiency, Compliance and Success Full supply chain management in clinical trial supply encompasses the comprehensive oversight...

Ancillaries play a crucial role in ensuring the smooth execution of clinical trials, encompassing a broad range of items, materials and...

Ryvu Therapeutics Announces Entering into Agreement with Clinical Services International (CSI) in the Area of Securing Venetoclax Supply...

How can you be sure that your comparator sourcing partner will provide you with the best available solution? How do you know that the...

How CSI used its scientific expertise at the protocol stage to provide flexibility in sourcing strategy and ensure high volumes of a...

How CSI delivered mission impossible: sourcing specific tested batches of an expensive oncology product from several European markets...

How CSI leveraged relationships with multiple manufacturers to urgently supply large quantities of a generic drug to a global Phase 3...

How CSI’s regulatory guidance and robust sourcing solutions ensured the success of a global flu vaccine trial that could not afford to...